US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about COPHF

Recent news which mentions COPHF

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
Tickers BETRF BRAXF COPHF PSIL
Tags artificial intelligence Psychedelics Investing Psychedelic/Assisted Therapies
From Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
Tickers COPHF MNMD
Tags MNMD Market News Markets
From Benzinga
Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings
Tickers COPHF
Tags PTSD Cannabis News
From Benzinga
KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD
Tickers COPHF KONEF
Tags Psychedelics Contracts Penny Stocks
From Benzinga
Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs
Tickers COPHF
Tags Jodi Scott Penny Stocks Market News
From Benzinga
Cannabis Movers & Shakers: Akerna, iAnthus, Cronos Group, WSU's Cannabis Research Center
Tickers CGC COPHF CRON ITHUF
Tags appointments Randy Maslow Penny Stocks
From Benzinga
Cronos Promotes John Griese, Former Exec At Nestlé, PepsiCo And Supreme Cannabis
Tickers CGC COPHF CRON NSRGY
Tags NSRGY Cannabis News
From Benzinga
Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A
Tickers COPHF FTRP MNMD MSSTF
Tags Penny Stocks COPHF Synthesis Institute
From Benzinga
Red Light Holland and Creso Pharma Call Off Psilocybin-Cannabis Merger
Tickers COPHF TRUFF
Tags Cannabis COPHF Benzinga
From Benzinga